Exploring the role of pharmacists in outpatient dialysis centers: A qualitative study of nephrologist views

Nephrology Dialysis Transplantation

Volumn 28, Issue 2, 2013, Pages 397-404

  Salgado, Teresa M ^a   Moles, Rebekah ^b   Benrimoj, Shalom I ^c   Fernandez Llimos, Fernando ^a  

^a RESEARCH INSTITUTE FOR MEDICINES IMED ULISBOA   (Portugal)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

Author keywords

Australia; dialysis centers; nephrologist opinions; pharmacists; Portugal

Indexed keywords

ADULT; ARTICLE; AUSTRALIA; CLINICAL PHARMACY; FEMALE; HEMODIALYSIS; HUMAN; MALE; MEDICATION ERROR; MEDICATION THERAPY MANAGEMENT; NEPHROLOGIST; PATIENT COMPLIANCE; PATIENT EDUCATION; PHARMACEUTICAL CARE; PHARMACIST; PHYSICIAN ATTITUDE; PORTUGAL; PRIORITY JOURNAL; QUALITATIVE RESEARCH; SEMI STRUCTURED INTERVIEW;

ADULT; AMBULATORY CARE FACILITIES; ATTITUDE OF HEALTH PERSONNEL; AUSTRALIA; FEMALE; HUMANS; INTERPROFESSIONAL RELATIONS; MALE; MEDICATION ERRORS; MIDDLE AGED; PATIENT COMPLIANCE; PHARMACISTS; PORTUGAL; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; SPECIALIZATION; SUBSTANCE-RELATED DISORDERS;

EID: 84874531487     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfs436     Document Type: Article

References (54)

1. Griffin JF. More physician-pharmacist cooperation needed. N Engl J Med 1986; 315: 1097 (Pubitemid 17170637)
2. Sweeney MA. Physician-pharmacist collaboration: a millennial paradigm to reduce medication errors. J Am Osteopath Assoc 2002; 102: 678-681 (Pubitemid 36008417)
3. Koshman SL, Charrois TL, Simpson SH et al. Pharmacist care of patients with heart failure: a systematic review of randomized trials. Arch Intern Med 2008; 168: 687-694 (Pubitemid 351563951)
4. Chisholm-Burns MA, Kim Lee J, Spivey CA et al. US pharmacists' effect as team members on patient care: systematic review and metaanalyses. Med Care 2010; 48: 923-933
5. Bailie GR, Romeo B. New York State primary care physicians' attitudes to community pharmacists' clinical services. Arch Intern Med 1996; 156: 1437-1441 (Pubitemid 26226938)
6. Bleiker P, Lewis A. Extending the role of community pharmacists: the views of GPs. Int J Pharm Pract 1998; 6: 140-144 (Pubitemid 28505422)
7. Smith WE, Ray MD, Shannon DM. Physicians' expectations of pharmacists. Am J Health Syst Pharm 2002; 59: 50-57 (Pubitemid 34415052)
8. Bryant LJ, Coster G, Gamble GD et al. General practitioners' and pharmacists' perceptions of the role of community pharmacists in delivering clinical services. Res Soc Admin Pharm 2009; 5: 347-362
9. Bradshaw SJ, Doucette WR. Community pharmacists as patient advocates: physician attitudes. J Am Pharm Assoc (Wash) 1998; 38: 598-602
10. Ellis BC, Dovey SM, Collins DM et al. General practitioners' views on the role of the community pharmacist. N Z Med J 1992; 105: 403-405
11. Teinila T, Kaunisvesi K, Airaksinen M. Primary care physicians' perceptions of medication errors and error prevention in cooperation with community pharmacists. Res Soc Admin Pharm 2011; 7: 162-179
12. Laubscher T, Evans C, Blackburn D et al. Collaboration between family physicians and community pharmacists to enhance adherence to chronic medications: opinions of Saskatchewan family physicians. Can Fam Phys 2009; 55: e69-75
13. Fairbanks RJ, Hildebrand JM, Kolstee KE et al. Medical and nursing staff highly value clinical pharmacists in the emergency department. Emerg Med J 2007; 24: 716-718
14. Kjeldsen LJ, Jensen TB, Jensen JJ. Physicians' evaluation of clinical pharmacy revealed increased focus on quality improvement and cost savings. Dan Med Bull 2011; 58: A4261
15. Salgado TM, Moles R, Benrimoj SI et al. Pharmacists' interventions in the management of patients with chronic kidney disease: a systematic review. Nephrol Dial Transplant 2012; 27: 276-292
16. Stemer G, Lemmens-Gruber R. Clinical pharmacy activities in chronic kidney disease and end-stage renal disease patients: a systematic literature review. BMC Nephrol 2011; 12: 35
17. Salgado TM, Moles R, Benrimoj SI et al. Exploring the role of renal pharmacists in outpatient dialysis centres: a qualitative study. Int J Clin Pharm 2012; 34: 569-578
18. Patton MQ. Qualitative Evaluation and Research Methods. 2nd edn. Newbury Park, CA: Sage, 1990
19. Whiteley AM, Whiteley J. The familiarization study in qualitative research: from theory to practice. Qual Res J 2006; 6: 69-85
20. Sorensen L, Stokes JA, Purdie DM et al. Medication reviews in the community: results of a randomized, controlled effectiveness trial. Br J Clin Pharmacol 2004; 58: 648-664 (Pubitemid 39665152)
21. Armour C, Bosnic-Anticevich S, Brillant M et al. Pharmacy Asthma Care Program (PACP) improves outcomes for patients in the community. Thorax 2007; 62: 496-502 (Pubitemid 46910127)
22. Krass I, Mitchell B, Song YJ et al. Diabetes Medication Assistance Service Stage 1: impact and sustainability of glycaemic and lipids control in patients with Type 2 diabetes. Diabet Med 2011; 28: 987-993
23. Marotti SB, Kerridge RK, Grimer MD. A randomised controlled trial of pharmacist medication histories and supplementary prescribing on medication errors in postoperative medications. Anaesth Intensive Care 2011; 39: 1064-1070
24. Vasileff HM, Whitten LE, Pink JA et al. The effect on medication errors of pharmacists charting medication in an emergency department. Pharm World Sci 2009; 31: 373-379
25. Crotty M, Rowett D, Spurling L et al. Does the addition of a pharmacist transition coordinator improve evidence-based medication management and health outcomes in older adults moving from the hospital to a long-term care facility? Results of a randomized, controlled trial. Am J Geriatr Pharmacother 2004; 2: 257-264 (Pubitemid 40378780)
26. Garcao JA, Cabrita J. Evaluation of a pharmaceutical care program for hypertensive patients in rural Portugal. J Am Pharm Assoc (Wash) 2002; 42: 858-864
27. Morgado M, Rolo S, Castelo-Branco M. Pharmacist intervention program to enhance hypertension control: a randomised controlled trial. Int J Clin Pharm 2011; 33: 132-140
28. Costa S, Santos C, Silveira J. Community pharmacy services in Portugal. Ann Pharmacother 2006; 40: 2228-2234 (Pubitemid 44954445)
29. Paulino E, Guerreiro MP, Cantrill JA et al. Community pharmacists' and physicians' inter-professional work: insights from qualitative studies with multiple stakeholders. Rev Port Clin Geral 2010; 26: 590-606
30. Bereznicki B, Peterson G, Jackson S et al. Perceived feasibility of a community pharmacy-based asthma intervention: a qualitative follow-up study. J Clin Pharm Ther 2011; 36: 348-355
31. Makowsky MJ, Schindel TJ, Rosenthal M et al. Collaboration between pharmacists, physicians and nurse practitioners: a qualitative investigation of working relationships in the inpatient medical setting. J Interprof Care 2009; 23: 169-184
32. Zillich AJ, McDonough RP, Carter BL et al. Influential characteristics of physician/pharmacist collaborative relationships. Ann Pharmacother 2004; 38: 764-770 (Pubitemid 38509049)
33. Sulick JA, Pathak DS. The perceived influence of clinical pharmacy services on physician prescribing behavior: a matched-pair comparison of pharmacists and physicians. Pharmacotherapy 1996; 16: 1133-1141 (Pubitemid 26403656)
34. Awad A, Matowe L, Capps P. Medical doctors' perceptions and expectations of the role of hospital pharmacists in Sudan. Pharm World Sci 2007; 29: 557-564 (Pubitemid 47389416)
35. Ritchey FJ, Raney MR. Medical role-task boundary maintenance: physicians' opinions on clinical pharmacy. Med Care 1981; 19: 90-103 (Pubitemid 11178591)
36. Pojskic N, Mackeigan L, Boon H et al. Ontario family physician readiness to collaborate with community pharmacists on drug therapy management. Res Soc Admin Pharm 2011; 7: 39-50
37. Ranelli PL, Biss J. Physicians' perceptions of communication with and responsibilities of pharmacists. J Am Pharm Assoc (Wash) 2000; 40: 625-630
38. Commonwealth of Australia, The Pharmacy Guild of Australia. The fifth community pharmacy agreement between the Commonwealth of Australia and the Pharmacy Guild of Australia. Camberra: Australian Government. http://www.health.gov.au/internet/main/publishing.nsf/Content/ C3DB799DB360AF0CCA25772000249FA8/$File/ 5CPA%20Agreement%2005%20August%202010.pdf. 7 September 2011, date last accessed.
39. van Mil JW. Pharmaceutical care in community pharmacy: practice and research in the Netherlands. Ann Pharmacother 2005; 39: 1720-1725 (Pubitemid 41393133)
40. Guignard E, Bugnon O. Pharmaceutical care in community pharmacies: practice and research in Switzerland. Ann Pharmacother 2006; 40: 512-517
41. Department of Health. Guidance for the Development of Consultant Pharmacist Posts. London: Department of Health, 2005
42. McKnight AG, Thomason AR. Pharmacists' advancing roles in drug and disease management: a review of states' legislation. J Am Pharm Assoc (2003) 2009; 49: 554-558
43. Punekar Y, Lin SW, Thomas J, 3rd. Progress of pharmacist collaborative practice: status of state laws and regulations and perceived impact of collaborative practice. J Am Pharm Assoc (2003) 2003; 43: 503-510
44. Kiel PJ, McCord AD. Pharmacist impact on clinical outcomes in a diabetes disease management program via collaborative practice. Ann Pharmacother 2005; 39: 1828-1832 (Pubitemid 41527695)
45. Leal S, Soto M. Chronic kidney disease risk reduction in a Hispanic population through pharmacist-based disease-state management. Adv Chronic Kidney Dis 2008; 15: 162-167 (Pubitemid 351335416)
46. Field HM. Increasing access to emergency contraceptive pills through state law enabled dependent pharmacist prescribers. UCLA Womens Law J 2000; 11: 141-253
47. Isetts BJ, Brown LM, Schondelmeyer SWet al. Quality assessment of a collaborative approach for decreasing drug-related morbidity and achieving therapeutic goals. Arch Intern Med 2003; 163: 1813-1820 (Pubitemid 36960929)
48. Alkhateeb FM, Unni E, Latif D et al. Physician attitudes toward collaborative agreements with pharmacists and their expectations of community pharmacists' responsibilities in West Virginia. J Am Pharm Assoc (2003) 2009; 49: 797-800
49. Quercia RA, Abrahams R, White CM et al. Cost Avoidance and Clinical Benefits Derived from a Pharmacy-Managed Anemia Program. Hosp Pharm 2001; 36: 169-175 (Pubitemid 32165103)
50. Kimura T, Arai M, Masuda H et al. Impact of a pharmacistimplemented anemia management in outpatients with end-stage renal disease in Japan. Biol Pharm Bull 2004; 27: 1831-1833 (Pubitemid 41701613)
51. Walton T, Holloway KP, Knauss MD. Pharmacist-Managed Anemia Program in an outpatient hemodialysis population. Hosp Pharm 2005; 40: 1051-1056 (Pubitemid 43041286)
52. Hassan Y, Al-Ramahi RJ, Aziz NA et al. Impact of a renal drug dosing service on dose adjustment in hospitalized patients with chronic kidney disease. Ann Pharmacother 2009; 43: 1598-1605
53. Farrell B, Pottie K, Woodend K et al. Shifts in expectations: evaluating physicians' perceptions as pharmacists become integrated into family practice. J Interprof Care 2010; 24: 80-89
54. Bowen GA. Naturalistic inquiry and the saturation concept: a research note. Qual Res 2008; 8: 137-152